{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:26:29Z","timestamp":1790083589175,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1038\/ki.2014.427","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T11:36:10Z","timestamp":1422444970000},"page":"1164-1175","source":"Crossref","is-referenced-by-count":51,"title":["Glycogen synthase kinase-3\u03b2 promotes cyst expansion in polycystic kidney disease"],"prefix":"10.1016","volume":"87","author":[{"given":"Shixin","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayakumar R.","family":"Kakade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Woodgett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin D.","family":"Suderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumitha","family":"Rajagopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2014.427_bb0010","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneph.2011.109","article-title":"Why kidneys fail in autosomal dominant polycystic kidney disease","volume":"7","author":"Grantham","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1038\/ki.2014.427_bb0015","doi-asserted-by":"crossref","first-page":"10679","DOI":"10.1073\/pnas.1016214108","article-title":"Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases","volume":"108","author":"Choi","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1038\/ki.2014.427_bb0020","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/ki.2013.501","article-title":"Renal cyst growth is the main determinant for hypertension and concentrating deficit in Pkd1-deficient mice","volume":"85","author":"Fonseca","year":"2014","journal-title":"Kidney Intl"},{"key":"10.1038\/ki.2014.427_bb0025","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat Med"},{"key":"10.1038\/ki.2014.427_bb0030","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1523-1755.2004.00945.x","article-title":"Cyclic AMP, at the hub of the cystic cycle","volume":"66","author":"Torres","year":"2004","journal-title":"Kidney Intl"},{"key":"10.1038\/ki.2014.427_bb0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: the last 3 years","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Intl"},{"key":"10.1038\/ki.2014.427_bb0040","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bbadis.2010.11.005","article-title":"Cyclic AMP-mediated cyst expansion","volume":"1812","author":"Wallace","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/ki.2014.427_bb0045","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0272-6386(97)90496-0","article-title":"Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease","volume":"30","author":"Yamaguchi","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2014.427_bb0050","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","article-title":"Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease","volume":"10","author":"Torres","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/ki.2014.427_bb0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1681\/ASN.2007060688","article-title":"Vasopressin directly regulates cyst growth in polycystic kidney disease","volume":"19","author":"Wang","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.427_bb0060","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0092-8674(01)00412-3","article-title":"Regulation of GSK-3: a cellular multiprocessor","volume":"105","author":"Harwood","year":"2001","journal-title":"Cell"},{"key":"10.1038\/ki.2014.427_bb0065","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnmol.2011.00040","article-title":"GSK-3: Functional Insights from cell biology and animal models","volume":"4","author":"Kaidanovich-Beilin","year":"2011","journal-title":"Front Mol Neurosci"},{"key":"10.1038\/ki.2014.427_bb0070","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1476-4598-9-144","article-title":"Glycogen synthase kinase 3 beta: can it be a target for oral cancer","volume":"9","author":"Mishra","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1038\/ki.2014.427_bb0075","first-page":"F995","article-title":"Mechanism of Li inhibition of vasopressin-sensitive adenylate cyclase in cultured renal epithelial cells","volume":"255","author":"Goldberg","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2014.427_bb0080","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1210\/endo-107-6-1693","article-title":"Lithium-induced polyuria: effect of lithium on adenylate cyclase and adenosine 3',5'-monophosphate phosphodiesterase in medullary ascending limb of Henle's loop and in medullary collecting tubules","volume":"107","author":"Jackson","year":"1980","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2014.427_bb0085","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1017\/S1461145707008395","article-title":"Lithium preferentially inhibits adenylyl cyclase V and VII isoforms","volume":"11","author":"Mann","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1038\/ki.2014.427_bb0090","first-page":"F505","article-title":"Cellular mechanism of lithium-induced nephrogenic diabetes insipidus in rats","volume":"261","author":"Yamaki","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1038\/ki.2014.427_bb0095","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1681\/ASN.2005080884","article-title":"Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity","volume":"17","author":"Li","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.427_bb0100","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1681\/ASN.2009060672","article-title":"GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity","volume":"21","author":"Rao","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.427_bb0105","doi-asserted-by":"crossref","first-page":"F1725","DOI":"10.1152\/ajprenal.90420.2008","article-title":"Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1","volume":"295","author":"Alcalay","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2014.427_bb0110","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/(SICI)1097-0185(199607)245:3<488::AID-AR5>3.0.CO;2-O","article-title":"Murine autosomal recessive polycystic kidney disease with multiorgan involvement induced by the cpk gene","volume":"245","author":"Gattone","year":"1996","journal-title":"Anat Rec"},{"key":"10.1038\/ki.2014.427_bb0115","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1172\/JCI0214099","article-title":"Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease","volume":"109","author":"Hou","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2014.427_bb0120","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1681\/ASN.V181048","article-title":"Elevated proto-oncogene expression in polycystic kidneys of the C57BL\/6\u2009J (cpk) mouse","volume":"1","author":"Cowley","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.427_bb0125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1520-6408(1999)24:3\/4<309::AID-DVG14>3.0.CO;2-5","article-title":"Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease","volume":"24","author":"Gattone","year":"1999","journal-title":"Dev Genet"},{"key":"10.1038\/ki.2014.427_bb0130","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1681\/ASN.2011010084","article-title":"Macrophages promote cyst growth in polycystic kidney disease","volume":"22","author":"Karihaloo","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.427_bb0135","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/hmg\/ddn039","article-title":"Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1","volume":"17","author":"Shibazaki","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1038\/ki.2014.427_bb0140","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1172\/JCI64401","article-title":"Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease","volume":"123","author":"Zhou","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2014.427_bb0145","doi-asserted-by":"crossref","first-page":"479249","DOI":"10.4061\/2011\/479249","article-title":"Deconstructing GSK-3: the fine regulation of its activity","volume":"2011","author":"Medina","year":"2011","journal-title":"Int J Alzheimers Dis"},{"key":"10.1038\/ki.2014.427_bb0150","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ki.2012.239","article-title":"Specific deletion of glycogen synthase kinase-3beta in the renal proximal tubule protects against acute nephrotoxic injury in mice","volume":"82","author":"Howard","year":"2012","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.427_bb0155","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1021\/jm011020u","article-title":"First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease","volume":"45","author":"Martinez","year":"2002","journal-title":"J Med Chem"},{"key":"10.1038\/ki.2014.427_bb0160","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.4049\/jimmunol.1203057","article-title":"Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3","volume":"190","author":"Beurel","year":"2013","journal-title":"J Immunol"},{"key":"10.1038\/ki.2014.427_bb0165","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.ackd.2010.01.002","article-title":"Molecular advances in autosomal dominant polycystic kidney disease","volume":"17","author":"Gallagher","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1038\/ki.2014.427_bb0170","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1046\/j.1523-1755.2002.0610s1125.x","article-title":"c-myc antisense oligonucleotide treatment ameliorates murine ARPKD","volume":"61","author":"Ricker","year":"2002","journal-title":"Kidney intl"},{"key":"10.1038\/ki.2014.427_bb0175","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1159\/000320149","article-title":"Early cyst growth is associated with the increased nuclear expression of cyclin D1\/Rb protein in an autosomal-recessive polycystic kidney disease rat model","volume":"117","author":"Schwensen","year":"2011","journal-title":"Nephron Exp Nephrol"},{"key":"10.1038\/ki.2014.427_bb0180","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2011.87","article-title":"WNT\/beta-catenin signaling in polycystic kidney disease","volume":"80","author":"Wuebken","year":"2011","journal-title":"Kidney intl"},{"key":"10.1038\/ki.2014.427_bb0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000421641","article-title":"Regulation of cell proliferation and fluid secretion in theprogressive enlargement of renal cysts","volume":"97","author":"Grantham","year":"1992","journal-title":"Contrib Nephrol"},{"key":"10.1038\/ki.2014.427_bb0190","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2014.427_bb0195","first-page":"469","article-title":"Regulation of cell cycle progression and apoptosis by the Ras\/Raf\/MEK\/ERK pathway (Review)","volume":"22","author":"Chang","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1038\/ki.2014.427_bb0200","first-page":"9643","article-title":"Unique and overlapping functions of GSK-3 isoforms in cellular differentiation, proliferation, and cardiovascular development","volume":"15","author":"Woodgett","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2014.427_bb0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ncpneph0070","article-title":"Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases","volume":"2","author":"Torres","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1038\/ki.2014.427_bb0210","first-page":"457","article-title":"Histogenesis of the renal cysts in adult (autosomal dominant) polycystic kidney disease: a histochemical study","volume":"1","author":"Verani","year":"1988","journal-title":"Mod Pathol"},{"key":"10.1038\/ki.2014.427_bb0215","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(00)81570-6","article-title":"Somatic inactivation of Pkd2 results in polycystic kidney disease","volume":"93","author":"Wu","year":"1998","journal-title":"Cell"},{"key":"10.1038\/ki.2014.427_bb0220","first-page":"213","article-title":"[Polycystic kidney disease in a patient using lithium chronically]","volume":"24","author":"Atagun","year":"2013","journal-title":"Turk Psikiyatri Derg"},{"key":"10.1038\/ki.2014.427_bb0225","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1148\/radiol.2292020758","article-title":"Chronic lithium nephropathy: MR imaging for diagnosis","volume":"229","author":"Farres","year":"2003","journal-title":"Radiology"},{"key":"10.1038\/ki.2014.427_bb0230","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0140-6736(10)60956-7","article-title":"Not all renal cysts are created equal","volume":"376","author":"Shah","year":"2010","journal-title":"Lancet"},{"key":"10.1038\/ki.2014.427_bb0235","doi-asserted-by":"crossref","first-page":"F455","DOI":"10.1152\/ajprenal.00144.2011","article-title":"Tissue injury after lithium treatment in human and rat postnatal kidney involves glycogen synthase kinase-3beta-positive epithelium","volume":"302","author":"Kjaersgaard","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2014.427_bb0240","doi-asserted-by":"crossref","first-page":"F39","DOI":"10.1152\/ajprenal.00383.2005","article-title":"Lithium treatment induces a marked proliferation of primarily principal cells in rat kidney inner medullary collecting duct","volume":"291","author":"Christensen","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2014.427_bb0245","doi-asserted-by":"crossref","first-page":"C952","DOI":"10.1152\/ajpcell.00266.2003","article-title":"Changes in cellular composition of kidney collecting duct cells in rats with lithium-induced NDI","volume":"286","author":"Christensen","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1038\/ki.2014.427_bb0250","series-title":"Nephrol Dial Transplant","article-title":"An mTOR kinase inhibitor slows disease progression in a rat model of polycystic kidney disease","author":"Ravichandran","year":"2014"},{"key":"10.1038\/ki.2014.427_bb0255","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.4161\/cc.22375","article-title":"CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD","volume":"11","author":"Bukanov","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1038\/ki.2014.427_bb0260","doi-asserted-by":"crossref","first-page":"12786","DOI":"10.1073\/pnas.1301904110","article-title":"Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease","volume":"110","author":"Seeger-Nukpezah","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2014.427_bb0265","doi-asserted-by":"crossref","first-page":"F1243","DOI":"10.1152\/ajprenal.00694.2013","article-title":"Effects of combined administration of rapamycin, tolvaptan, and AEZ-131 on the progression of polycystic disease in PCK rats","volume":"306","author":"Sabbatini","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2014.427_bb0270","first-page":"4257","article-title":"Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 Model","volume":"11","author":"Hopp","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2014.427_bb0275","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease","volume":"60","author":"Harris","year":"2009","journal-title":"Annu Rev Med"},{"key":"10.1038\/ki.2014.427_bb0280","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1172\/JCI64313","article-title":"Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity","volume":"122","author":"Hopp","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2014.427_bb0285","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/bcp.12136","article-title":"New treatments for autosomal dominant polycystic kidney disease","volume":"76","author":"Chang","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1038\/ki.2014.427_bb0290","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","article-title":"Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks","volume":"18","author":"Song","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1038\/ki.2014.427_bb0295","doi-asserted-by":"crossref","first-page":"F494","DOI":"10.1152\/ajprenal.00416.2006","article-title":"Canonical WNT signaling during kidney development","volume":"293","author":"Iglesias","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2014.427_bb0300","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ki.2011.56","article-title":"T-cell factor\/beta-catenin activity is suppressed in two different models of autosomal dominant polycystic kidney disease","volume":"80","author":"Miller","year":"2011","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.427_bb0305","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1242\/dev.006544","article-title":"Beta-catenin\/TCF\/Lef controls a differentiation-associated transcriptional program in renal epithelial progenitors","volume":"134","author":"Schmidt-Ott","year":"2007","journal-title":"Development"},{"key":"10.1038\/ki.2014.427_bb0310","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/ki.2010.534","article-title":"The canonical Wnt signaling pathway is not involved in renal cyst development in the kidneys of inv mutant mice","volume":"79","author":"Sugiyama","year":"2011","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2014.427_bb0315","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35017574","article-title":"Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation","volume":"406","author":"Hoeflich","year":"2000","journal-title":"Nature"},{"key":"10.1038\/ki.2014.427_bb0320","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2217\/14796694.2.1.91","article-title":"Targeting GSK-3: a promising approach for cancer therapy?","volume":"2","author":"Ougolkov","year":"2006","journal-title":"Future Oncol"},{"key":"10.1038\/ki.2014.427_bb0325","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm979","article-title":"Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor","volume":"10","author":"Sato","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/ki.2014.427_bb0330","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nm1339","article-title":"Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation","volume":"12","author":"Trowbridge","year":"2006","journal-title":"Nat Med"},{"key":"10.1038\/ki.2014.427_bb0335","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1172\/JCI36245","article-title":"Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation","volume":"118","author":"Kerkela","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2014.427_bb0340","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/j.1349-7006.2007.00545.x","article-title":"Inhibition of GSK-3 beta activity attenuates proliferation of human colon cancer cells in rodents","volume":"98","author":"Shakoori","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1038\/ki.2014.427_bb0345","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1158\/0008-5472.CAN-04-3642","article-title":"Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells","volume":"65","author":"Ougolkov","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/ki.2014.427_bb0350","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1158\/1535-7163.MCT-06-0665","article-title":"Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells","volume":"6","author":"Kunnimalaiyaan","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/ki.2014.427_bb0355","doi-asserted-by":"crossref","first-page":"e60383","DOI":"10.1371\/journal.pone.0060383","article-title":"CG0009, a novel glycogen synthase kinase 3 inhibitor, induces cell death through cyclin D1 depletion in breast cancer cells","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/ki.2014.427_bb0360","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.cr.7310078","article-title":"Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells","volume":"16","author":"Cao","year":"2006","journal-title":"Cell Res"},{"key":"10.1038\/ki.2014.427_bb0365","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/sj.bjc.6605437","article-title":"Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma","volume":"101","author":"Bilim","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1038\/ki.2014.427_bb0370","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1681\/ASN.2004090800","article-title":"Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease","volume":"17","author":"Omori","year":"2006","journal-title":"J Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815301447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815301447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T18:47:47Z","timestamp":1747507667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815301447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0085253815301447"],"URL":"https:\/\/doi.org\/10.1038\/ki.2014.427","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}